These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6488044)

  • 1. Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age.
    Marcusson JO; Morgan DG; Winblad B; Finch CE
    Brain Res; 1984 Oct; 311(1):51-6. PubMed ID: 6488044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of serotonin binding sites on human platelets.
    McBride PA; Mann JJ; McEwen B; Biegon A
    Life Sci; 1983 Nov; 33(20):2033-41. PubMed ID: 6645789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]ketanserin binds to non-5-HT2 sites in rabbit cerebral cortex and neostriatum.
    Dewar KM; Lima L; Reader TA
    Neurochem Res; 1990 May; 15(5):507-14. PubMed ID: 2115148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites.
    Blackshear MA; Friedman RL; Sanders-Bush E
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):125-9. PubMed ID: 6646240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.
    López-Giménez JF; Villazón M; Brea J; Loza MI; Palacios JM; Mengod G; Vilaró MT
    Mol Pharmacol; 2001 Oct; 60(4):690-9. PubMed ID: 11562430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists.
    Glennon RA; Metwally K; Dukat M; Ismaiel AM; De los Angeles J; Herndon J; Teitler M; Khorana N
    Curr Top Med Chem; 2002 Jun; 2(6):539-58. PubMed ID: 12052193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]ketanserin (serotonin type 2) binding increases in rat cortex following basal forebrain lesions with ibotenic acid.
    Wenk GL; Engisch KL
    J Neurochem; 1986 Sep; 47(3):845-50. PubMed ID: 2942641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional serotonin receptor studies: chronic methysergide treatment induces a selective and dose-dependent decrease in serotonin-2 receptors in mouse cerebral cortex.
    May PC; Morgan DG; Finch CE
    Life Sci; 1986 May; 38(19):1741-7. PubMed ID: 3702603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin receptors in hippocampus and frontal cortex.
    Seeman P; Westman K; Coscina D; Warsh JJ
    Eur J Pharmacol; 1980 Aug; 66(2-3):179-91. PubMed ID: 7439270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
    Noisin EL; Thomas WE
    Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist and antagonist binding to rabbit cortical 5-HT2A receptors: opposite effects of magnesium.
    Aloyo VJ; Salt GL; Hoffman ME; Harvey JA
    Ann N Y Acad Sci; 1998 Dec; 861():280. PubMed ID: 9928290
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenergic regulation of [3H]ketanserin binding sites during immobilization stress in the rat frontal cortex.
    Torda T; Murgas K; Cechova E; Kiss A; Saavedra JM
    Brain Res; 1990 Sep; 527(2):198-203. PubMed ID: 1701336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.
    Steward LJ; Ge J; Bentley KR; Barber PC; Hope AG; Lambert JJ; Peters JA; Blackburn TP; Barnes NM
    Br J Pharmacol; 1995 Sep; 116(2):1781-8. PubMed ID: 8528560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
    Pinto W; Battaglia G
    Mol Pharmacol; 1994 Dec; 46(6):1111-9. PubMed ID: 7808431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.
    Joyce JN; Shane A; Lexow N; Winokur A; Casanova MF; Kleinman JE
    Neuropsychopharmacology; 1993 Jun; 8(4):315-36. PubMed ID: 8512620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites.
    Gandolfi O; Barbaccia ML; Costa E
    Life Sci; 1985 Feb; 36(8):713-21. PubMed ID: 2983168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.